S6-4. CIDP syndrome with anti-NF155 and -CNTN1 IgG4 antibodies
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Neurophysiology"
DOI: 10.1016/j.clinph.2018.02.041
Abstract: In recent years, the specific autoantibodies for some CIDP patients groups have been found. Neurofascin155 (NF155) and contactin-1 (CNTN1), which are adhesion molecules at paranodal axo-glial junction, are the novel target antigens. The patients with… read more here.
Keywords: cntn1 igg4; igg4 antibodies; anti nf155; nf155 cntn1 ... See more keywords
Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1121705
Abstract: Background Recent studies have reported that similar to other IgG4 autoimmune diseases, such as muscle-specific kinase antibody-associated myasthenia gravis, most anti-neurofascin-155 (anti-NF155) nodopathies respond well to rituximab treatment, regardless of the dosage. However, there are… read more here.
Keywords: treatment; anti neurofascin; anti nf155; antibody ... See more keywords
Dissociation of axo-glial junction in anti-neurofascin 155 chronic inflammatory demyelinating polyneuropathy.
Sign Up to like & getrecommendations! Published in 2020 at "Clinical neuropathology"
DOI: 10.5414/np301309
Abstract: AIMS A subset of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by the presence of anti-neurofascin 155 (anti-NF155) autoantibodies. In this paper, we investigated an anti-NF155 CIDP patient via clinical, electrophysiological, and neuropathological tests. MATERIALS… read more here.
Keywords: anti nf155; inflammatory demyelinating; anti neurofascin; axo glial ... See more keywords